Biocorrx (BICX) to Release Earnings on Monday

Biocorrx (OTCMKTS:BICX) is expected to be posting its resultson Monday, March 30th. Analysts expect Biocorrx to post earnings of ($0.06) per share and revenue of $0.22 million for the quarter.

Biocorrx Price Performance

BICX stock opened at $0.40 on Friday. The business has a 50 day moving average of $0.35 and a 200 day moving average of $0.36. The firm has a market cap of $10.56 million, a PE ratio of -1.25 and a beta of 0.33. Biocorrx has a twelve month low of $0.20 and a twelve month high of $0.50.

About Biocorrx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.